Nicholas Smith
Equibles does not estimate personal net worth.
Get an email with a short summary when Alto Neuroscience, Inc. publishes a filing, an earnings call transcript or a press release.
Get ANRO alertsAbout Nicholas Smith
Nicholas Smith is recorded as CFO at Alto Neuroscience, Inc. (ANRO). The newest filing on record that lists Nicholas Smith as CFO at Alto Neuroscience, Inc. (ANRO) is dated March 26, 2026. The proxy statement of Alto Neuroscience, Inc. reports total compensation of $1,541,585 for Nicholas Smith in fiscal 2025, including a base salary of $493,720. Disclosed compensation is on record for 2 fiscal years. Alto Neuroscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Alto Neuroscience, Inc. includes Amit Etkin (CEO and Board Member), Michael Hanley (COO), Andrew Dreyfus (Board Member) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed March 26, 2026
Company network
Leadership on record at Alto Neuroscience, Inc.
- Amit Etkin CEO, Board Member
- Michael Hanley COO
- Andrew Dreyfus Board Member
- Andrew Miller, Ph.D. Board Member
- Christopher Nixon Cox Board Member
- Gwill York Board Member
- Husseini Manji Board Member
- Maha Radhakrishnan, M.D. Board Member
- Ramiro (Raymond) Sanchez, M.D. Board Member
- Raymond Sanchez Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Alto Neuroscience, Inc. (ANRO) | Chief Financial Officer and Chief Business Officer | $493,720 | $1,541,585 |
| 2024 | Alto Neuroscience, Inc. (ANRO) | Chief Financial Officer and Chief Business Officer | $466,511 | $1,995,964 |
Recent activity
No call appearances or filed executive changes recorded yet.